This Combined Synopsis/Solicitation opportunity from Department Of Defense was posted on September 24, 2020. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

ProHeart 12 (moxidectin) Injectable Heartworm Prevention

Closed

FA301621Q0141Federal

Submission Closed09/28/2020, 10:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supplier of Red Sealing Compound (NSN 8030015650423)

Defense Logistics Agency

POSTED

DEADLINE

Supply of 4% Chlorhexidine Gluconate Surgical Detergent

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Isoniazid Tablet Manufacturing

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Tolnaftate Powder, USP 1%

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0122

Solicitation SPE2DP-27-T-0122 is a procurement request by the Defense Logistics Agency for surgical detergent containing 4% chlorhexidine gluconate, identified by NSN 6505-01-101-3759. The requirement is for one 8 oz bottle to be delivered FOB Destination to the USNS ABLE TAGOS 20. The item is FDA regulated and must have a total shelf life of 24 months, with at least 21 months remaining upon delivery to the government. The original required delivery date is October 21, 2026, with a delivery lead time of 20 days after award. The contract mandates strict adherence to Medical Marking Standard No. 1C and DLA packaging requirements RP001. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it must comply with ASTM D3951. Offerors must submit quotes via DIBBS by October 26, 2026, and provide a Safety Data Sheet meeting 29 CFR 1910.1200(g) prior to award. The procurement is subject to destination inspection under FAR 52.246-2 and incorporates the Buy American Act and HUBZone price evaluation preferences. Invoicing and receiving reports must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TETRAHYDROZOLINE HYDRO

Solicitation # SPE2DP-27-T-0130

Solicitation SPE2DP-27-T-0130 is a fixed-price contract issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Tetrahydrozoline Hydrochloride Ophthalmic Solution, USP (NSN 6505-00-139-4600). The requirement consists of one bottle of 0.05 percent, 15 ml solution, to be delivered FOB Destination to the Naval Med Readiness Logistics Cmd in Williamsburg, Virginia, with a required delivery date of October 21, 2026. The item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. The contract mandates strict adherence to commercial packaging standards, requiring sealed unit containers and exterior shipping containers that protect contents from damage. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and preservation must comply with MIL-STD-2073-1E and special packaging instructions MPWN00001. Additionally, the contractor must comply with FDA regulations, the Buy American and Balance of Payments Program, and specific hazardous material labeling requirements under 29 CFR 1910.1200. Inspection and acceptance will occur at the destination point. Invoicing and payment are to be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0126

Solicitation SPE2DP-27-T-0126 is a fixed-price procurement issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the supply of 15 bottles of Tolnaftate Powder, USP 1%, 45 GM (NSN 6505014807897). The contract requires delivery within 20 days after receipt of order, with an original required delivery date of October 21, 2026. The shipment is destined for the USS Lewis B Puller ESB 3, with both inspection and acceptance occurring at the destination. The item is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Compliance requirements include adherence to the DLA Master List of Technical and Quality Requirements, which takes precedence over ASTM D3951 for commercial packaging. All packaging must be marked and labeled according to MIL-STD-129 and Medical Marking Standard No. 1, with palletization following RP001 requirements. If the material is deemed hazardous per FED-STD-313, it must be packaged according to TQ requirement IP025. Administratively, the contract mandates the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and requires compliance with the Buy American and Balance of Payments Program, the Berry Amendment, and DFARS 252.204-7012 for safeguarding covered defense information.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ENROFLOXACIN INJECTION

Solicitation # SPE2DP-27-T-0128

Solicitation SPE2DP-27-T-0128, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of six units of veterinary Enrofloxacin Injection. This FDA-regulated drug is an intramuscular solution for dogs, formulated at 2.27% (2.5mg/kg) in 20ML doses for managing bacterial pathogens. The item has a non-extendable shelf life of 24 months and requires specific storage conditions: protection from direct sunlight, no freezing, and maintenance at or below 25 degrees Celsius, with permitted excursions up to 40 degrees Celsius. Delivery is set for October 19, 2026, with FOB Destination terms. The shipping destination is the USA Med Mat Ctr EUR in Kaiserslautern, Germany. Packaging must be commercial and compliant with MIL-STD-2073-1E and DLA requirement RP001, while marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various FAR and DFARS clauses, including those for safeguarding covered defense information, the Buy American Act, and the prohibition of covered defense telecommunications equipment. Invoicing and payment requests must be processed electronically via the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CHARCOAL, ACTIVATED, SUS

Solicitation # SPE2DP-27-T-0125

Solicitation SPE2DP-27-T-0125 is a request for quotations from the Defense Logistics Agency for the procurement of activated charcoal suspension, identified by NSN 6505-01-282-8880. The requirement consists of five bottles, each with a volume of 240 ml and a weight of 50 grams. The items must be delivered to the USS Lewis B Puller ESB 3 by October 21, 2026, with a delivery lead time of 20 days. The product has a non-extendable shelf life of 36 months, and no more than five months may have elapsed from the date of manufacture to the date of delivery to the government. Storage must be maintained at a controlled room temperature between 20 and 25 degrees Celsius. Packaging must be commercial and include suitable sealed unit containers and exterior shipping containers to ensure safe delivery. Marking and labeling must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and labels must include the NSN, manufacturer and CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. The contract is governed by the DLA Master Solicitation for Automated Simplified Acquisitions Revision 105 and includes various FAR and DFARS clauses covering small business representations, hazardous material identification, and cybersecurity requirements. Inspection and acceptance will take place at the destination. Quotations are due by October 26, 2026, to the DLA Troop Support Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0123

Solicitation SPE2DP-27-T-0123 is a request for quotations from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Isoniazid Tablets, USP, 300 MG. The requirement consists of two line items totaling three bottles, with each bottle containing 100 tablets. The items must be stored at medical controlled room temperature and have a non-extendable shelf life of 36 months. Delivery is required within 20 days after order, with an original required delivery date of October 21, 2026. Shipments are destined for the USS Lewis B Puller ESB 3 and the USS Kingsville LCS 36, with FOB and inspection/acceptance points set at the destination. The contract mandates strict adherence to DLA packaging and marking standards, including MIL-STD-129 and Medical Marking Standard No. 1. Palletization must follow RP001, and non-hazardous materials must be packaged per ASTM D3951, though the DLA Master List of Technical and Quality Requirements takes precedence. The procurement is governed by NAICS code 325412 and includes various FAR and DFARS clauses regarding fixed-price supply, safeguarding covered defense information, and the Buy American Act. Invoicing must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MOXIFLOXACIN HYDROCHLO

Solicitation # SPE2DP-27-T-0127

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE AND EPINEP

Solicitation # SPE2DP-27-T-0124

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 6 days

General Info

Agency

Department Of Defense → FA3016 502 Cons Cl

Contract Value

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

JBSA Lackland, TX, 78236, USA

Set-Aside

NONE

Awardee

COVETRUS NORTH AMERICA, LLC

Award Issued Date

10/23/2020, 12:00:00 AM UTC

Documents

Atch1-+Questions+and+Answers.docx

RFQ+ProHeart+17Sep2020.docx

RFQ+ProHeart+24Sep2020.docx

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

2 updates

PhaseClosed

PostedSep 17

Combined Synopsis

Notice updatedSep 23

The notice description changed.

Notice updatedSep 24

Response deadline changed from Sep 25, 2020 to Sep 28, 2020. The notice description changed.

Response DeadlineSep 28

Deadline has passed

Submission Closed

09/28/2020, 10:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → FA3016 502 Cons Cl

Contacts2 people available

OfficeJBSA LACKLAND, TX, 78236-5286, USA

Organization / AgencyDepartment Of Defense → FA3016 502 Cons Cl

Office AddressJBSA LACKLAND, TX, 78236-5286, USA

Contacts

A1C Bismark Badu

Heather A. Sorensen

Full Description

Amendment 2: The purpose of this amendment is to extend the response due date to 28 Sept 2020-Monday at 5PM CST and update the RFQ. Please refer to the new attachment, RFQ dated 24 Sept 2020. =============================================================================== Amendment 1: The purpose of this amendment is to upload Questions and Answers to this solicitation. =============================================================================== The attached is an RFQ for a 5-year Blanket Purchase Agreement (BPA) for ProHeart 12 (Moxidectin) injectable heartworm prevention for Military Working Dog. Please respond to this BPA RFQ by emailing quotes to: A1C Bismark Badu via e-mail: bismark.badu.gh@us.af.mil no later than close of business on 25 September 2020 - Friday